Antihistamine OTC Switch: WellPoint Will Not Sue If FDA Refuses Petition

20 Oct 2003

• By The Pink Sheet

WellPoint will not take legal action against FDA should the agency reject the health insurer's citizen petition to force an OTC switch of prescription low- and non-sedating antihistamines

Antihistamine OTC Switch: WellPoint Will Not Sue If FDA Refuses Petition

More from Archive

More from Pink Sheet